Skip to main content
OpenTrials

Clinical trial condition

HIV Infections

Explore clinical trials studying HIV Infections. Study availability and eligibility vary by location and protocol.

3,321 public trials 106 recruiting studies
Refine in advanced search Browse all conditions

HIV Infections trial results

Completed

Safety of and Immune Response to Two Different HIV Vaccines, Each Followed by a Adenoviral Vaccine Boost, in HIV Uninfected Adults

NCT00270218

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Alabama Vaccine CRS Birmingham, Alabama, United States
  • San Francisco Vaccine and Prevention CRS San Francisco, California, United States
  • NY Blood Ctr./Union Square CRS New York, United States
  • HIV Prevention & Treatment CRS New York, United States
View Trial Details
Completed

Safety of and Immune Response to a New HIV Vaccine: HIV CTL MEP

NCT00076037

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Alabama Vaccine CRS Birmingham, Alabama, United States
  • San Francisco Vaccine and Prevention CRS San Francisco, California, United States
  • Johns Hopkins Bloomberg School of Public Health,Ctr for Immunization Research,Project SAVE-Baltimore Baltimore, Maryland, United States
  • Saint Louis Univ. School of Medicine, HVTU St Louis, Missouri, United States
View Trial Details
Completed

A Study of LIPO-5 and ALVAC-HIV (vCP1452) as Possible HIV Vaccines

NCT00076063

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Alabama Vaccine CRS Birmingham, Alabama, United States
  • Johns Hopkins Bloomberg School of Public Health,Ctr for Immunization Research,Project SAVE-Baltimore Baltimore, Maryland, United States
  • Project Brave HIV Vaccine CRS Baltimore, Maryland, United States
  • Brigham and Women's Hosp. CRS Boston, Massachusetts, United States
View Trial Details
Completed

Safety of and Immune Response to an HIV Preventive Vaccine (HIV-1 Gag DNA Alone or With IL-15 DNA) Given With or Without 2 Different Booster Vaccinations in HIV Uninfected Adults

NCT00115960

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Brigham and Women's Hosp. CRS Boston, Massachusetts, United States
  • NY Blood Ctr./Union Square CRS New York, United States
  • HIV Prevention & Treatment CRS New York, United States
  • Univ. of Rochester HVTN CRS Rochester, New York, United States
View Trial Details
Completed

Safety of and Immune Response to a DNA HIV Vaccine Followed by an Adenoviral Vaccine Boost Given Three Different Ways to HIV Uninfected Adults

NCT00384787

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Alabama Vaccine CRS Birmingham, Alabama, United States
  • Brigham and Women's Hospital Vaccine CRS (BWH VCRS) Boston, Massachusetts, United States
  • NY Blood Ctr./Union Square CRS New York, United States
  • Columbia P&S CRS New York, United States
View Trial Details
Completed

Safety and Immune Response Study of High-Dose Canarypox ALVAC-HIV Vaccine in Healthy, HIV Uninfected Adults

NCT00027261

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +12 more
Locations
  • Alabama Vaccine CRS Birmingham, Alabama, United States
  • San Francisco Vaccine and Prevention CRS San Francisco, California, United States
  • UCSF, Gen. Clinical Research Ctr., Mt. Zion Hosp. San Francisco, California, United States
  • Project Brave HIV Vaccine CRS Baltimore, Maryland, United States
View all 13 locations
View Trial Details
Completed

Safety of and Immune Response to an HIV-1 DNA Vaccine (VRC HIVDNA009-00-VP) in HIV Uninfected Adults

NCT00071851

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Alabama Vaccine CRS Birmingham, Alabama, United States
  • San Francisco Vaccine and Prevention CRS San Francisco, California, United States
  • Project Brave HIV Vaccine CRS Baltimore, Maryland, United States
  • Johns Hopkins Bloomberg School of Public Health,Ctr for Immunization Research,Project SAVE-Baltimore Baltimore, Maryland, United States
View all 14 locations
View Trial Details

Related conditions